Periodic Reporting for period 1 - Envue (Business strategy of nanofluidic chips for next-generation bioanalysis solutions to develop future medicines)
Reporting period: 2023-07-01 to 2024-04-30
This project focused on evaluating and enhancing our nanofluidic chip production process, refining our business model, and developing our intellectual property strategy. These efforts aimed to drive our technological innovation, foster sustainable growth, and strengthen global competitiveness for Envue.
The work performed in this project consisted of three main parts:
(i) the nanofluidic chip production process,
(ii) business development, and business model,
(iii) intellectual property analysis and strategy,
Main achievements:
(i) successfully optimized nanofluidic chip production processes, achieving increased yield from 75% to 90%,
(ii) developed an updated business model that aligned better with market demands and findings,
(iii) conducted patent analyses and recommendations for an IP strategy forward.
(i) the nanofluidic chip production process,
(ii) business development, and business model,
(iii) intellectual property analysis and strategy,
Main achievements:
(i) successfully optimized nanofluidic chip production processes, achieving increased yield from 75% to 90%,
(ii) developed an updated business model that aligned better with market demands and findings,
(iii) conducted patent analyses and recommendations for an IP strategy forward.
The Women TechEU project has significantly advanced our nanofluidic chip production, refined business strategies, and strengthened intellectual property protections. This enhances our technological leadership and market position.
Key needs for further success include support for extensive product development, global commercialization, ongoing IP management, fundraising, and regulatory alignment.
Key needs for further success include support for extensive product development, global commercialization, ongoing IP management, fundraising, and regulatory alignment.